Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Aaron

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
American Journal of Respiratory and Critical Care Medicine|February 17, 2001
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseS D Aaron, J B Angel, M Lunau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 31, 2012
Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosisV Waters, J E A Zlosnik, Y C W Yau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 24, 2011
Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosisA Burkett, K L Vandemheen, T Giesbrecht-Lewis, et al.
Thorax|July 16, 2008
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPDM Najafzadeh, C A Marra, M Sadatsafavi, et al.
The European Respiratory Journal|October 2, 2004
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosisS D Aaron, D Kottachchi, W J Ferris, et al.
Thorax|August 19, 2007
Counting, analysing and reporting exacerbations of COPD in randomised controlled trialsS D Aaron, D Fergusson, G B Marks, et al.
Thorax|April 8, 2014
Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based studyW C Tan, J Bourbeau, P Hernandez, et al.
Thorax|July 18, 2006
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteriaJ K Block, K L Vandemheen, E Tullis, et al.
International Journal of Circumpolar Health|May 8, 2020
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP studyG G Alvarez, D Van Dyk, R Mallick, et al.
Thorax|June 7, 2015
Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD studyW C Tan, D D Sin, J Bourbeau, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Respiratory and Critical Care Medicine|February 17, 2001
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseS D Aaron, J B Angel, M Lunau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 31, 2012
Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosisV Waters, J E A Zlosnik, Y C W Yau, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 24, 2011
Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosisA Burkett, K L Vandemheen, T Giesbrecht-Lewis, et al.
Thorax|July 16, 2008
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPDM Najafzadeh, C A Marra, M Sadatsafavi, et al.
The European Respiratory Journal|October 2, 2004
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosisS D Aaron, D Kottachchi, W J Ferris, et al.
Thorax|August 19, 2007
Counting, analysing and reporting exacerbations of COPD in randomised controlled trialsS D Aaron, D Fergusson, G B Marks, et al.
Thorax|April 8, 2014
Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based studyW C Tan, J Bourbeau, P Hernandez, et al.
Thorax|July 18, 2006
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteriaJ K Block, K L Vandemheen, E Tullis, et al.
International Journal of Circumpolar Health|May 8, 2020
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP studyG G Alvarez, D Van Dyk, R Mallick, et al.
Thorax|June 7, 2015
Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD studyW C Tan, D D Sin, J Bourbeau, et al.
Pageof 3